ELEVAI Labs Inc. ( (ELAB) ) has shared an announcement.
On March 18, 2025, PMGC Holdings Inc. repurchased shares from existing shareholders who directly contacted the company, with the transaction closing on the same day. The company announced on March 21, 2025, that it may consider further repurchases from other investors, depending on market conditions, but it is not conducting a formal share repurchase program.
More about ELEVAI Labs Inc.
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The company currently owns three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC, and is committed to exploring opportunities in multiple sectors to maximize growth and value.
YTD Price Performance: -64.82%
Average Trading Volume: 268,774
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.71M
For an in-depth examination of ELAB stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com